Fulgent Genetics, Inc.

NasdaqGM:FLGT Stock Report

Market Cap: US$573.5m

Fulgent Genetics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:FLGT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Dec 24SellUS$28,372Jian XieIndividual1,455US$19.50
03 Dec 24SellUS$26,773Hanlin GaoIndividual1,373US$19.50
25 Nov 24SellUS$12,581Jian XieIndividual689US$18.26
25 Nov 24SellUS$40,663Ming HsiehIndividual2,227US$18.26
25 Nov 24SellUS$9,075Hanlin GaoIndividual497US$18.26
03 Sep 24SellUS$33,007Hanlin GaoIndividual1,503US$21.96
03 Sep 24SellUS$36,763Paul KimIndividual1,674US$21.96
03 Sep 24SellUS$35,006Jian XieIndividual1,594US$21.96
27 Aug 24SellUS$16,737Paul KimIndividual733US$22.83
27 Aug 24SellUS$52,813Ming HsiehIndividual2,313US$22.83
27 Aug 24SellUS$16,326Jian XieIndividual715US$22.83
27 Aug 24SellUS$12,855Hanlin GaoIndividual563US$22.83

Insider Trading Volume

Insider Buying: FLGT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of FLGT?
Owner TypeNumber of SharesOwnership Percentage
State or Government5,0780.0166%
General Public3,997,84413.1%
Individual Insiders10,180,31133.3%
Institutions16,403,57853.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.2%.

Top Shareholders

Top 25 shareholders own 76.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28.5%
Ming Hsieh
8,728,443US$163.7m0.03%no data
12.8%
BlackRock, Inc.
3,923,013US$73.6m0.05%no data
4.74%
The Vanguard Group, Inc.
1,448,671US$27.2m0.92%no data
4.15%
Millennium Management LLC
1,270,649US$23.8m32.5%0.02%
3.62%
Dimensional Fund Advisors LP
1,106,394US$20.7m-9.03%no data
2.8%
Hanlin Gao
856,647US$16.1m0.4%no data
2.59%
State Street Global Advisors, Inc.
793,545US$14.9m1.39%no data
2.33%
Park West Asset Management LLC
713,584US$13.4m-14.4%1.04%
1.64%
Geode Capital Management, LLC
502,869US$9.4m2.72%no data
1.47%
Jian Xie
448,670US$8.4m1.25%no data
1.16%
Columbia Management Investment Advisers, LLC
356,291US$6.7m0.44%no data
0.99%
Point72 Asset Management, L.P.
304,049US$5.7m0%0.01%
0.99%
Citadel Advisors LLC
302,918US$5.7m62.7%0.01%
0.98%
Acadian Asset Management LLC
300,578US$5.6m379%0.01%
0.85%
Morgan Stanley, Investment Banking and Brokerage Investments
261,213US$4.9m53.5%no data
0.82%
Invenomic Capital Management LP
249,747US$4.7m98.9%0.65%
0.8%
Charles Schwab Investment Management, Inc.
245,188US$4.6m-8.94%no data
0.7%
Northern Trust Global Investments
213,071US$4.0m-2.05%no data
0.68%
Bridgeway Capital Management, LLC
208,512US$3.9m-0.42%0.06%
0.67%
Eaton Vance Management
204,138US$3.8m3.88%no data
0.61%
BNY Asset Management
187,997US$3.5m-6.56%no data
0.59%
JPMorgan Chase & Co, Brokerage and Securities Investments
181,639US$3.4m2,070%no data
0.57%
Barclays PLC Private Banking & Investment Banking Investment
174,855US$3.3m22.7%no data
0.48%
Invesco Capital Management LLC
147,840US$2.8m-4.53%no data
0.47%
JP Morgan Asset Management
142,622US$2.7m4.46%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 07:27
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fulgent Genetics, Inc. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Karen KoskiBTIG
Andrew CooperCGS International
Erin Wilson WrightCredit Suisse